期刊文献+

胃神经内分泌肿瘤临床病理特点及预后分析 被引量:34

Clinicopathological characteristics and prognostic analysis of neuroendocrine neoplasms of the stomach
原文传递
导出
摘要 目的:探讨胃神经内分泌肿瘤临床病理特点及其预后。方法:回顾性分析近11年收治的52例胃神经内分泌肿瘤的临床及病理资料。结果:全组男39例,女13例,平均年龄59岁。根据WHO(2010)神经内分泌肿瘤新分类标准,其中神经内分泌瘤(NET)19例(1级12例,2级7例),神经内分泌癌(NEC)29例,混合性腺神经内分泌癌(MANEC)4例。病变发生于贲门、胃底31例(59.6%),胃体11例(21.2%),胃窦10例(19.2%)。主要临床表现为上腹饱胀不适和吞咽困难。50例接受手术治疗,其中NET患者经内镜切除5例,胃壁局部切除3例,根治性胃切除11例,术后病理显示14例(73.7%)肿瘤局限在黏膜及黏膜下层,淋巴结转移4例(21.1%),脉管瘤栓1例(5.3%);NEC及MANEC患者行开放式根治性手术17例,姑息性手术13例,单纯探查手术1例,术后病理显示29例(96.7%)肿瘤侵及或穿透浆膜,淋巴结转移27例(90%),脉管瘤栓16例(53.3%)。随访2~106个月,19例NET术后局部复发2例(10.5%),远处转移3例(15.8%),死亡2例(10.5%),1,3,5年生存率分别为100%,89%和82%;29例NEC术后局部复发1例(3.4%),远处转移25例(86.2%),死亡21例(72.4%),1,3,5年生存率分别为69%,43%和21%;4例MANEC术后远处转移3例,死亡3例。结论:不同分类的胃神经内分泌肿瘤的临床病理特点及预后各有不同,NET多为早期病变,治疗效果较好;NEC及MANEC恶性程度高,侵袭性强,预后较差。 Objective: To analyze the clinicopathological characteristics and outcomes of gastric neuroendocrine neoplasms. Methods: The clinical and pathological data of 52 patients with gastric neuroendocrine neoplasms admitted to our hospital in recent 11 years were retrospectively analyzed. Results: There were 38 males and 12 females in the whole group, with average age of 54 years. According tothe new WHO classification (2010) of neuroendocrine neoplasms, there were 19 cases of neuroendocrine tumor (NET) (12 cases of G 1 and 7 cases of G2), 29 cases of neuroendocrine carcinoma (NEC) and 4 cases of mixed adenoneuroendocrine carcinoma (MANEC). The lesions of the patients were located on the cardia/ fundus (n=31, 59.6%), corpus (n=1 1, 21.2%) and antrum (n=10, 19.2%) of the stomach, respectively. The main clinical manifestations were epigastric distension/discomfort and dysphagia. Fifty patients underwent surgical treatment. Among the NET patients, 5 cases underwent endoscopic excision, 3 cases underwent local full-thickness excision of the gastric wall and 11 cases underwent radical gastrectomy, and the postoperative pathology demonstrated that the lesions of 14 cases were confined to the mucosal or submucosal layer (73.7%), 4 cases had lymph node metastases (21.1%) and intravascular tumor thrombus occurred in 1 case (5.3%). Among the NEC and MANEC patients, 17 cases underwent open radical gastrectom)513 cases underwent palliative surgical treatment and 1 case had a surgical exploration only, and the postoperative pathology showed that the lesions of 29 cases infiltrated or penetrated the serosal layer (96.7%), 27 cases had lymph node metastases (90%) and intravascular tumor thrombi were found in 16 cases (53.3%). The follow-up period ranged from 2 to 106 months. Of the 19 NET patients, 2 cases had local recurrence (10.5%), 3 cases had distant metastases (5.8%) and 2 cases died (10.5%), and the 1, 3, 5-year survival rate was 100%, 89% and 82%, respectively; of the 29 NEC patients, 1 case had local recurrence (3.4%), 25 cases had distant metastases (86.2%) and 21 cases died (72.4%), and the 1, 3, 5-year survival rate was 69%, 43% and 21%, respectively; of the 4 MANEC patients, distant metastases occurred in 3 cases and 3 cases died. Conclusion: The clinicopathological characteristics and prognosis of gastric neuroendocrine neoplasms vary considerably among different types. Most NETs are of early stage disease and have favorable therapeutic efficac). However, NECs and MANECs are of a high degree of malignancy and invasiveness, and have a poor prognosis.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第6期704-708,共5页 China Journal of General Surgery
关键词 胃肿瘤/外科学 神经内分泌 预后 Stomach Neoplasms/surg Carcinoma, Neuroendocrine Prognosis
  • 相关文献

参考文献15

  • 1中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,40(4):257-262. 被引量:294
  • 2Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?[J]. Am J Gastroenterol, 2004, 99(1):23-32.
  • 3Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors[J]. Cancer, 2003, 97(4):934-959.
  • 4叶必星,姜柳琴,林琳.胃肠神经内分泌肿瘤的临床研究概述[J].中华消化杂志,2010,30(2):139-141. 被引量:3
  • 5Bordi C, Yu JY, Baggi MT, et al. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases[J]. Cancer, 1991, 67(3):663-672.
  • 6Sj0blom SM. Clinical presentation and prognosis of gastrointestinal carcinoid turnours [J]. Scand J Gastroenterol, 1988, 23(7):779-787.
  • 7Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas:pathogenesis,pathology and behavior[J]. World J Surg, 1996, 20(2): 168-172.
  • 8Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study[J]. Gastroenterology, 1993, 104(4):994-1006.
  • 9Ruszniewski P, Delle Fave G, Cadiot G, et al. Well-differentiated gastric tumors/carcinomas[J]. Neuroendocrinology, 2006, 84(3):158-164.
  • 10盖保东,肖钟迪.胃肠胰腺神经内分泌肿瘤诊治进展[J].中华内分泌外科杂志,2009,3(2):76-79. 被引量:15

二级参考文献67

  • 1Kulke MH,Lenz H J,Meropol NJ,et al.Activity of sunitinib in patients with advanced neuroendocrine tumors.J Clin Oncol,2008,26:3403-3410.
  • 2Duran I,Kortmansky J,Singh D,et al.A phase Ⅱ clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.Br J Cancer,2006,95:1148-1154.
  • 3Yao JC,Lombard-Bohas C,Baudin E,et al.A phase Ⅱ trial of daily oral RAD001 (everolimus) in patients with metastatic pancreatic neuroendocrine tumors (NET) after failure of cytotoxic chemotherapy.2009 Gastrointestinal Cancers Symposium.(abstract 122).
  • 4Kunnimalaiyaan M,Ndiaye M,Chen H.Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.Surgery,2007,142:959-964.
  • 5Greenblatt DY,Kunnimalaiyaan M,Chen H.Raf-1 activation in gastrointestinal carcinoid cells decreases tumor cell adhesion.Am J Surg,2007,193:331-335.
  • 6Auer A,yon Blume J,Sturany S,et al.Role of the regulatory domain of protein kinase D2 in phorbol ester binding,catalytic activity,and nucleocytoplasmic shuttling.Mol Biol Cell,2005,16:4375-4385.
  • 7Jackson LN,Li J,Chen LA,et al.Overexpression of wildtype PKD2 leads to increased proliferation and invasion of BON endocrine cells.Biochem Biophys Res Commun,2006,348:945-949.
  • 8Von Wichert G,Edenfeld T,yon Blume J,et al.Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cells.Cell Signal,2008,20:925-934.
  • 9Ferolla P,Faggiano A,Mansueto G,et al.The biological characterization of neuroendocrine tumors:the role of neuroendocrine markers.J Endocrinol Invest,2008,31:277-286.
  • 10Berkovic MC,JokiC M,Marout J,et al.IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors(GEP-NETs).Exp Mol Pathol,2007,83:474-479.

共引文献314

同被引文献169

引证文献34

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部